These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22381412)

  • 21. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
    Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
    Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thromboembolic complications after total hip arthroplasty.
    Kassim RA; Saleh KJ; Badra M; Moran T; Esterberg JL
    J South Orthop Assoc; 2003; 12(2):103-5. PubMed ID: 12882249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis.
    Kerr J; Linkins LA
    Thromb Haemost; 2010 Jan; 103(1):123-8. PubMed ID: 20062935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
    Kwong LM
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
    Nielsen JD
    Ugeskr Laeger; 2005 May; 167(21):2261-5. PubMed ID: 15962850
    [No Abstract]   [Full Text] [Related]  

  • 26. Frequency and timing of clinical venous thromboembolism after major joint surgery.
    Bjørnarå BT; Gudmundsen TE; Dahl OE
    J Bone Joint Surg Br; 2006 Mar; 88(3):386-91. PubMed ID: 16498018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
    Ghosh A; Best AJ; Rudge SJ; Chatterji U
    J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New oral antithrombotic agents for the prevention of deep venous thrombosis and pulmonary embolism in orthopedic surgery.
    Merli GJ
    Orthopedics; 2010 Sep; 33(9 Suppl):27-32. PubMed ID: 20839720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for thromboprophylaxis in lower joint arthroplasty.
    Colwell CW
    Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers to the optimal use of anticoagulants after orthopaedic surgery.
    Borris LC
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1441-5. PubMed ID: 18841341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep vein thrombosis prophylaxis.
    Weber KL; Zuckerman JD; Watters WC; Turkelson CM
    Chest; 2009 Dec; 136(6):1699-1700. PubMed ID: 19995776
    [No Abstract]   [Full Text] [Related]  

  • 32. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
    Ageno W
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current recommendations for extended out-of-hospital thromboprophylaxis following total hip arthroplasty.
    Krotenberg R
    Am J Orthop (Belle Mead NJ); 2004 Apr; 33(4):180-4. PubMed ID: 15132325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the evidence for and against thromboprophylaxis in total hip replacement.
    Maruthappu M; Nagendran M; Sugand K; Bulstrode CK
    Acta Orthop Belg; 2011 Oct; 77(5):583-9. PubMed ID: 22187830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T; Malý R; Urban K; Sponer P
    Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthopaedic surgery as a model for drug development in thrombosis.
    Dahl OE
    Drugs; 2004; 64 Suppl 1():17-25. PubMed ID: 15586624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
    Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
    Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment.
    Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ
    Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of thromboprophylaxis in the management of total hip and knee arthroplasty.
    Skinner HB; Schulz MM
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):20-30. PubMed ID: 12349892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.